Results 11 to 20 of about 6,477 (171)

The use of kDNA minicircle subclass relative abundance to differentiate between Leishmania (L.) infantum and Leishmania (L.) amazonensis [PDF]

open access: yesParasites & Vectors, 2017
Background Leishmaniasis is a neglected disease caused by many Leishmania species, belonging to subgenera Leishmania (Leishmania) and Leishmania (Viannia).
Marcello Ceccarelli   +7 more
doaj   +4 more sources

Metabolomic Reprogramming of C57BL/6-Macrophages during Early Infection with L. amazonensis [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Leishmania survival inside macrophages depends on factors that lead to the immune response evasion during the infection. In this context, the metabolic scenario of the host cell–parasite relationship can be crucial to understanding how this parasite can survive inside host cells due to the host’s metabolic pathways reprogramming. In this work, we aimed
Maricruz Mamani-Huanca   +5 more
openaire   +3 more sources

Tocopherol biosynthesis in Leishmania (L.) amazonensis promastigotes [PDF]

open access: yesFEBS Open Bio, 2019
Leishmaniasis is a neglected disease caused by a trypanosomatid protozoan of the genus Leishmania. Most drugs used to treat leishmaniasis are highly toxic, and the emergence of drug‐resistant strains has been observed. Therefore, new therapeutic targets against leishmaniasis are required. Several isoprenoid compounds, including dolichols or ubiquinones,
José Mário F. Balanco   +5 more
openaire   +4 more sources

Comparing the Antileishmanial Activity of Gold(I) and Gold(III) Compounds in L. amazonensis and L. braziliensis in Vitro [PDF]

open access: yesChemMedChem, 2020
AbstractAbstract: A series of mononuclear coordination or organometallic AuI/AuIII complexes (1–9) have been comparatively studied in vitro for their antileishmanial activity against promastigotes and amastigotes, the clinically relevant parasite form, of Leishmania amazonensis and Leishmania braziliensis.
Karen Minori   +4 more
openaire   +4 more sources

Leishmania (L.) amazonensis LaLRR17 increases parasite entry in macrophage by a mechanism dependent on GRP78 [PDF]

open access: yesParasitology, 2023
AbstractLeishmaniases affect 12 million people worldwide. They are caused by Leishmania spp., protozoan parasites transmitted to mammals by female phlebotomine flies. During the life cycle, promastigote forms of the parasite live in the gut of infected sandflies and convert into amastigotes inside the vertebrate macrophages.
Mauricio S. Peña   +10 more
openaire   +4 more sources

Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis [PDF]

open access: yesPLOS Neglected Tropical Diseases, 2019
Diffuse cutaneous leishmaniasis (DCL) is a rare form of leishmaniasis where parasites grow uncontrolled in diffuse lesions across the skin. Meta-transcriptomic analysis of biopsies from DCL patients infected with Leishmania amazonensis demonstrated an infiltration of atypical B cells producing a surprising preponderance of the IgG4 isotype. DCL lesions
Stephen M. Christensen   +5 more
openaire   +5 more sources

FVB/NJ strain as a mouse model for cutaneous leishmaniasis by Leishmania (L.) amazonensis [PDF]

open access: yesMemórias do Instituto Oswaldo Cruz
Leishmaniases encompass a spectrum of neglected diseases caused by parasites of the genus Leishmania, grouped in two forms: tegumentary and visceral leishmaniasis.In this study, we propose Friend Virus B NIH Jackson (FVB/NJ) mouse strain as a new experimental model of infection with Leishmania (Leishmania) amazonensis, the second most prevalent agent ...
Guilherme Moreira Paiva Carrara   +1 more
openaire   +4 more sources

Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors [PDF]

open access: yesScientific Reports
AbstractLeishmaniasis is a disease caused by a protozoan of the genus Leishmania, affecting millions of people, mainly in tropical countries, due to poor social conditions and low economic development. First-line chemotherapeutic agents involve highly toxic pentavalent antimonials, while treatment failure is mainly due to the emergence of drug ...
Priscila Goes Camargo   +4 more
openaire   +4 more sources

Nitro-Heterocyclic compounds induce apoptosis-like effects in Leishmania (L). amazonensis promastigotes [PDF]

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2019
Three drugs - pentavalent antimonials, amphotericin B and pentamidine - are currently used for leishmaniasis treatment. They are administered for long periods, only parenterally, and have high cardiac, renal and hepatic toxicities. Therefore, the investigation of new compounds is required.
Daiane Barros Dias Mendonça   +7 more
openaire   +6 more sources

Metacaspase-binding peptide inhibits heat shock-induced death in Leishmania (L.) amazonensis [PDF]

open access: yesCell Death & Disease, 2017
AbstractLeishmania (Leishmania) amazonensis is an important agent of cutaneous leishmaniasis in Brazil. This parasite faces cell death in some situations during transmission to the vertebrate host, and this process seems to be dependent on the activity of metacaspase (MCA), an enzyme bearing trypsin-like activity present in protozoans, plants and fungi.
Mauricio S Peña   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy